Security key
89422G107
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)
CUSIP: 89422G107
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 102,162,218
- Total 13F value
- $3,903,903,645
- Share change
- -2,694,713
- Put/Call ratio
- 129%
- SEC-reported price per share
- $38.21
- Number of holders
- 276
- Value change
- +$7,451,854
- Number of buys
- 157
- Number of sells
- 129
- Shares outstanding
- 92,930,114
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
276
Top holders
10
TVTX full security history
Ownership snapshot
Full 13F holder table
Travere Therapeutics, Inc. SEC filings
Travere Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 12%
13D/G row: Janus Henderson Group Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Janus Henderson Group Ltd. leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership
Top 5
Janus Henderson Group Ltd.
12%
FMR LLC
12%
ARMISTICE CAPITAL, LLC
10%
BlackRock, Inc.
7.5%
STATE STREET CORP
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Janus Henderson Group Ltd. |
13D/G
13F
JANUS HENDERSON GROUP PLC · Company
|
12%
|
$253,331,874
10,599,660 shares
|
-$17,690,876 | 30 Sep 2025 |
| FMR LLC |
13D/G
13F
Company
|
12%
|
$403,768,185
10,567,303 shares
|
$0 | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$160,703,600
6,724,000 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.5%
from 13D/G
|
$193,867,597
8,322,610 shares
mixed-class rows
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
5.3%
|
$138,466,547
4,756,666 shares
|
$0 | 31 Dec 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
4.8%
|
$124,537,820
4,278,180 shares
|
-$17,973,533 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
276
Shares
102,162,218
Rows available
276
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
235
Q4 2025 holders
276
Holder diff
41
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|